MV-αCD38, but not MV-Edm, significantly attenuated the tumorigenicity of CHO-CD38 cells in vivo.

Mice received CHO-CD38 premixed with MV-αCD38 (solid line) or MV-Edm (dotted line). Cumulative survival of mice was plotted. The survival curves are statistically significant (P < .001).